Stock THAR THARIMMUNE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Tharimmune, Inc.

Equities

THAR

US4327053090

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
5.11 USD -1.16% Intraday chart for Tharimmune, Inc. +13.81% -33.07%
May. 25 Certain Warrants of Tharimmune, Inc. are subject to a Lock-Up Agreement Ending on 25-MAY-2024. CI
May. 25 Certain Options of Tharimmune, Inc. are subject to a Lock-Up Agreement Ending on 25-MAY-2024. CI

Evolution of the average Target Price on Tharimmune, Inc.

Price target over the last 5 years

History of analyst recommendation changes

fa29113bc57fcbb1cebe.s4J3U33E66cmJbSp7n0GwyZ2Kw_9kvMcnUEfqL9u7zY.67IbYjqMud0WQtbxpzJ-sFwaZjiWx8B-pXZX-fpei3uHsRU5PvydlFV9gA~866dc911e87eea5d769fc24a40f1564a

Analyst Recommendations on Tharimmune, Inc.

Dawson James Downgrades Hillstream BioPharma to Neutral From Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
5.11 USD
Average target price
75 USD
Spread / Average Target
+1,367.71%
High Price Target
75 USD
Spread / Highest target
+1,367.71%
Low Price Target
75 USD
Spread / Lowest Target
+1,367.71%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Tharimmune, Inc.

Dawson James

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. THAR Stock
  4. Consensus Tharimmune, Inc.